Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-07

Clinical Trial Update: A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 double-blind, controlled study of aripiprazole in patients with co-morbid schizophrenia and cocaine dependence; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Paul Saenger | Conditions: Schizophrenia, Cocaine Dependence | Phase 2 | Status: UNKNOWN